IOVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Iovance Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 9.27 USD 7.79% Market Closed

Market Cap: $4.1B

	Iovance Biotherapeutics Inc NASDAQ:IOVA	US
Y	Yankuang Energy Group Co Ltd XMUN:YZCA	CN
A	Axon Enterprise Inc XMUN:TCS	US

Profitability Summary

Iovance Biotherapeutics Inc's profitability score is 19/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

48%

Negative 3Y Average Gross Margin

-190%

Gross Margin is Increasing

-754% > 48%

Negative Operating Margin

-93%

Negative 3Y Average Operating Margin

-10 759%

Operating Margin is Increasing

-178 496% > -93%

Negative Net Margin

-89%

Negative 3Y Average Net Margin

-10 399%

Net Margin is Increasing

-174 517% > -89%

Negative Free Cash Flow Margin

-91%

Negative 3Y Average Free Cash Flow Margin

-9 109%

Free Cash Flow Margin is Increasing

-147 783% > -91%

Negative ROE

-40%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-90%

ROIC is Increasing

-133% > -51%

View All

Hide

Collapse

19 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.